Overview

An Open Study for Steroid Resistant, Non-Thymectomized MG Patients

Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate the efficacy and safety for steroid resistant, non-thymectomized MG patients.
Phase:
Phase 3
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Tacrolimus